Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic factors influencing the development of vincristine-induced neurotoxicity.

Expert opinion on drug metabolism & toxicology - 1 Feb 2021

Pozzi Eleonora, Fumagalli Giulia, Chiorazzi Alessia, Canta Annalisa, Cavaletti Guido

Abstract excerpt

Introduction: One of the most common side effects during vincristine (VCR) use is the establishment of VCR-induced peripheral neuropathy (VIPN). Among several risk factors that can influence the development of VIPN, such as cumulative dose and patient's age, sex, ethnicity, and genetic variants, this review is focused on the genetic variability. Areas covered: A literature research was performed firstly using the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Phytogenic
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neurotoxicity Syndromes

Share to Peripheral Nervous System Diseases

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Risk Factors

Share to Vincristine

Source

Identifiers

PMID: 33283553
DOI: 10.1080/17425255.2021.1855141

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic factors influencing the development of vincristine-induced neurotoxicity.PMID 33283553Read ↗

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk FactorSemantic proximity Read ↗

Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology PatientsSemantic proximity Read ↗

CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.Semantic proximity Read ↗

Genomic variations associated with risk and protection against vincristine-induced peripheral neuropathy in pediatric cancer patientsSemantic proximity Read ↗

Association of CEP72 rs924607 TT Genotype with Vincristine-induced Peripheral Neuropathy Measured by Motor Nerve Conduction Studies.Semantic proximity Read ↗

The molecular genetics of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.Semantic proximity Read ↗

A machine learning model using SNPs obtained from a genome-wide association study predicts the onset of vincristine-induced peripheral neuropathy.Semantic proximity Read ↗

The Pharmacogenomics of Vincristine-Induced Neuropathy: On Pins and Needles.Semantic proximity Read ↗

A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral NeuropathySemantic proximity Read ↗

Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy GenesSemantic proximity Read ↗

Association of CYP3A5 Expression and Vincristine Neurotoxicity in Pediatric Malignancies in Turkish Population.Semantic proximity Read ↗

Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Studies Related to Vincristine-Induced Peripheral Neuropathy in Chinese Pediatric ALL Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.